Skip to main content
. 2019 Dec 3;20(23):6091. doi: 10.3390/ijms20236091
ADT androgen deprivation therapy
AR androgen receptor
AREG amphiregulin
BPH benign prostatic hyperplasia
BIC bicalutamide
CGS celecoxib-controlled gene set
COX-2 cyclooxygenase-2
CRPC castration-resistant prostate cancer
DHT 5-α-dihydrotestosterone
DSigDB Drug Signature Database
EGF epidermal growth factor
EGFR-Erb epidermal growth factor receptor
GO-BP gene ontology-biological process
GSK3β glycogen synthase 3β
H&E hematoxylin and eosin
hnRNP K heterogeneous nuclear ribonucleoprotein K
mHSPC metastatic hormone-sensitive PCa
NSAIDs non-steroidal anti-inflammatory drugs
PARP-1 poly (ADP-ribose) polymerase-1
PCa prostate cancer
P38 p38MAPK
PPI protein–protein interaction